A comprehensive ankle plating portfolio, designed with the proven technology of Arsenal Foot Plating System, expands offerings to address both tri-malleolar and intra-articular fracture patterns

WILMINGTON, Del. — DJO® is now part of the Enovis™ family.* Enovis Corporation, an innovation-driven medical technology growth company, announced today the launch of the Arsenal Ankle Plating System™. This system consists of 37 anatomically designed plates throughout nine plate families, offering a plating solution for any ankle fracture.

The Arsenal Ankle Plating System is the latest addition to Enovis’ suite of foot and ankle products and an expansion of Arsenal Foot Plating System, leveraging its history of proven results and pioneering technology.

“I am excited to see the technological advancements and trusted results from the Arsenal Foot Plating system applied to a broader set of indications throughout the ankle,” stated Matthew Herring, MD. “The plates are stout where it matters and sleek where needed, which makes a difference when treating complex ankle and distal tibia fractures in the OR.”

The variable angle locking technology, allowing a 60° cone of angulation, multi-lock functionality, accepting repeatable lock and relock of screw to plate interface, and dual lead screws that the Arsenal Ankle Plating System offers, makes for a powerful combination of patented and innovative solutions addressing all types of fracture personalities.

“Our Arsenal product line was created to disrupt existing technology,” said Gary Justak, President and General Manager of Enovis Foot & Ankle. “In addition to the standard ankle fracture plating options available today, this system features multiple solutions for malleoli fractures including a modernized spin of the proven AO technique of tension band wiring. These are just a couple of reasons why we are proud to introduce this system as we continue our growth journey in the Foot & Ankle market.”

Read more about Arsenal Ankle Plating System here.

Dr. Herring is a paid consultant at DJO.

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com/DJO.

* DJO Foot and Ankle (“DJO”) is excited to announce that its parent company, Colfax Corporation, has changed its name to Enovis Corporation. As part of our rebranding initiative, DJO is now part of the Enovis family. DJO continues to be wholly owned by Enovis Corporation, and DJO will continue to operate as an active legal entity under the ownership of Enovis Corporation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220615005248/en/

Megan Foltz Megan.foltz@enovis.com 609.680.0996

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

A welcome email is on its way. If you don't see it, please check your junk folder.

The next issue of Financial Post Top Stories will soon be in your inbox.

We encountered an issue signing you up. Please try again

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

365 Bloor Street East, Toronto, Ontario, M4W 3L4

© 2022 Financial Post, a division of Postmedia Network Inc. All rights reserved. Unauthorized distribution, transmission or republication strictly prohibited.

This website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Service and Privacy Policy.